Sensus Healthcare (SRTS) EV to EBITDA (2017 - 2025)

Sensus Healthcare has reported EV to EBITDA for 9 years, with the latest figure at 13.8 in Q4 2025.

• On a quarterly basis, EV to EBITDA fell 125.86% year-over-year to 13.8 in Q4 2025; TTM through Dec 2025 was 4.22, a 137.03% decrease from a year earlier, with the FY2025 full-year figure at 4.21, down 137.03% from the prior year.
• EV to EBITDA was 13.8 for Q4 2025 at Sensus Healthcare, down from 10.58 in the prior quarter.
• The five-year high for EV to EBITDA was 222.72 in Q3 2021, with the low at 173.05 in Q2 2021.
• Average EV to EBITDA over 5 years is 9.94, with a median of 9.63 recorded in 2023.
• The largest YoY upside for EV to EBITDA was 2093.75% in 2021 against a maximum downside of 1308.57% in 2021.
• Over 5 years, EV to EBITDA stood at 19.83 in 2021, then increased by 16.18% to 23.03 in 2022, then tumbled by 87.94% to 2.78 in 2023, then surged by 1820.39% to 53.36 in 2024, then slumped by 125.86% to 13.8 in 2025.
• The last three EV to EBITDA figures came in at 13.8 (Q4 2025), 10.58 (Q3 2025), and 28.7 (Q2 2025), per Business Quant data.